Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor
Schizophrenia is a chronic disease affecting 1% worldwide population, of which 30% are refractory to the available treatments: thus, searching for new pharmacological targets is imperative. The acute and repeated ketamine administration are validated preclinical models that recreate the behavioral a...
Guardado en:
| Autores principales: | Occhieppo, Victoria Belén, Basmadjian, Osvaldo Martín, Marchese, Natalia Andrea, Jaime, Andrea, Pérez, Mariela Fernanda, Baiardi, Gustavo Carlos, Bregonzio, Claudia |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Español |
| Publicado: |
2022
|
| Materias: | |
| Acceso en línea: | http://pa.bibdigital.ucc.edu.ar/3294/1/A_Occhieppo_Basmadjian_Marchese.pdf |
| Aporte de: |
Ejemplares similares
-
Participación de los receptores de Angiotensina AT1 de la Amigdala en la respuesta al miedo potenciado. Role of Amygdalar Angiotensin AT1 receptors in response to fear potentiated
por: Baiardi, Gustavo Carlos, et al.
Publicado: (2009) -
Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies
por: Larenza, M. P., et al.
Publicado: (2007) -
Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
por: Basmadjian, Osvaldo M., et al.
Publicado: (2024) -
Participación de los receptores de angiotensina at1 de la amigdala en la respuesta al miedo potenciado
por: Baiardi, Gustavo Carlos, et al.
Publicado: (2012) -
Unraveling the Lagged Effect of Hydro-meteorological Conditions On the Trophic State of a Reservoir By Applying Dynamic Regression
por: Andreoni, Pablo F., et al.
Publicado: (2022)